Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry.
Journal
European journal of rheumatology
ISSN: 2147-9720
Titre abrégé: Eur J Rheumatol
Pays: Turkey
ID NLM: 101656068
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
01
08
2019
accepted:
16
10
2019
pubmed:
11
1
2020
medline:
11
1
2020
entrez:
11
1
2020
Statut:
ppublish
Résumé
Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology. Within the PsA international database (PSART-ID), 571 patients had PSI, while 322 of these also showed body surface area (BSA). Correlations between PSI, BSA, and other patient- and physician-reported outcomes were investigated. There was a good correlation between PSI and BSA (r=0.546, p<0.001), which was even higher for mild psoriasis (BSA<3 (n=164): r=0.608, p<0.001). PSI significantly correlated with fatigue, pain, and patient and physician global parameters (p<0.001). PSI has a good correlation with other patient- and physician-reported outcomes, and our findings support its use in rheumatology practice.
Identifiants
pubmed: 31922480
pii: eurjrheum.2019.19126
doi: 10.5152/eurjrheum.2019.19126
pmc: PMC7343223
doi:
Types de publication
Journal Article
Langues
eng
Pagination
64-67Références
Rheumatology (Oxford). 2017 Nov 1;56(11):2031-2032
pubmed: 28968764
Ann Rheum Dis. 2010 Jan;69(1):48-53
pubmed: 19147615
J Dermatolog Treat. 2016;27(3):224-7
pubmed: 26447179
J Am Acad Dermatol. 2015 Mar;72(3):436-439.e1
pubmed: 25553889
J Dermatolog Treat. 2014 Feb;25(1):8-14
pubmed: 23339373
Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii65-8; discussion ii69-73
pubmed: 15708941
J Dermatolog Treat. 2013 Aug;24(4):255-60
pubmed: 23249143
J Rheumatol. 2016 Feb;43(2):343-9
pubmed: 26773108
Rheumatology (Oxford). 2017 Feb;56(2):279-286
pubmed: 27794533
J Dermatolog Treat. 2013 Oct;24(5):356-60
pubmed: 23092173